SRI International-医療機器分野:企業M&A・提携分析

◆英語タイトル:SRI International - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011436
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economic development, education and learning, energy and green tech, security and defense, sensing, space and radar, security and defense, robotics among others. SRI’s biomedical sector offers basic research on disease mechanisms, biologic drug discovery and development, nonclinical contract services, laboratory experiments, computer simulations, testing, behavioral pharmacology and other programs. It serves government, corporations, commercial businesses, startup companies, industry consortiums, private foundations and venture firms in the US. SRI is headquartered in Menlo Park, California, the US.

SRI International – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SRI International, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SRI International, Medical Equipment Deals By Type, 2011 to YTD 2017 6
SRI International, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SRI International, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
SRI International, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SRI International, Medical Equipment, Deal Details 10
Partnerships 10
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 10
Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 11
SRI International Enters Into Co-Development Agreement With CTK Biotech 12
Equity Offering 13
Ancora Medical Technology Spin Out from SRI International 13
SRI International Spins Off Superflex 14
SRI International – Key Competitors 15
SRI International – Key Employees 16
SRI International – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Strategy And Business Planning 20
Apr 21, 2016: SRI International Spins Off Superflex to Help People Achieve Their Physical Potential 20
Corporate Communications 21
May 19, 2016: SRI International Appoints Two New Leaders to its Executive Team 21
Mar 22, 2016: SRI International Adds New Members to Board of Directors 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
SRI International, Medical Equipment, Key Facts 2
SRI International, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
SRI International, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SRI International, Medical Equipment Deals By Type, 2011 to YTD 2017 6
SRI International, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SRI International, Deals By Market, 2011 to YTD 2017 8
SRI International, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 10
Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 11
SRI International Enters Into Co-Development Agreement With CTK Biotech 12
Ancora Medical Technology Spin Out from SRI International 13
SRI International Spins Off Superflex 14
SRI International, Key Competitors 15
SRI International, Key Employees 16
SRI International, Other Locations 18
SRI International, Subsidiaries 19

★海外企業調査レポート[SRI International-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Communications Construction Co Ltd:戦略・SWOT・企業財務分析
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Presbia Plc (LENS):医療機器:M&Aディール及び事業提携情報
    Summary Presbia Plc (Presbia) is a medical device company. The company develops presbyopia-correcting presbia flexivue microlens, a solutions for the age-related loss of the ability to read or focus on near objects. Its microlens helps people to read newspapers, restaurant menus, cell phone messages …
  • Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company’s tools assist physicians in the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer …
  • Myelin Repair Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Myelin Repair Foundation (MRF) is a medical research organization that discovers and develops myelin repair therapeutics for multiple sclerosis. The organization publishes various peer-reviewed scientific articles, identifies different myelin repair treatment targets and discovers multiple r …
  • AbbVie Inc (ABBV)-製薬・医療分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • Ellomay Capital Ltd (ELLO):企業の財務・戦略的SWOT分析
    Summary Ellomay Capital Ltd (Ellomay), formerly NUR Macroprinters Ltd, is an energy and infrastructure consulting company that provides renewable energy, oil and gas exploration, and clean energy solutions. The company offers renewable energy services such as installation of photovoltaic plants, man …
  • Valneva SE (VLA):企業の財務・戦略的SWOT分析
    Valneva SE (VLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Esso (Thailand) PCL (ESSO):企業の財務・戦略的SWOT分析
    Esso (Thailand) PCL (ESSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Rotala Plc:企業の戦略・SWOT・財務情報
    Rotala Plc - Strategy, SWOT and Corporate Finance Report Summary Rotala Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • gel-e Inc:製品パイプライン分析
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc is a medical device company that offers products for the treatment of acute wounds. The company's products include spray foams, bandages, gels, films, and band-aids. It offers proprietary technology platform that helps in development of w …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, urology and electrosurgery, perinatology, respiratory and OEM products. Its blood pressure monitor …
  • Isagenix International LLC:企業の戦略的SWOT分析
    Isagenix International LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidia …
  • Dongbu Insurance Co., Ltd.:企業の戦略・SWOT・財務情報
    Dongbu Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dongbu Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Flint Group SA:企業の戦略的SWOT分析
    Flint Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Omega Pharma NV-製薬・医療分野:企業M&A・提携分析
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • Tarsa Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the …
  • Triphase Accelerator Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Triphase Accelerator Corp (Triphase Accelerator) is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products comprise marizomib, a brain-penetrant proteasome inhibitor, which is developed in both intravenou …
  • Prologis, Inc.:企業の戦略・SWOT・財務情報
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆